Sodium Butyrate Powder 99% 99% White to almost white powder
8 Inquiries
156-54-7
Industrial Grade
99%
25KG/BAG
2026-10-09
Acesulfame k,Aspartame,BCAA(Keratin hydrolyzed),Beta-alanine,Citric Acid,Conjugated Linoleic Acid Powder
-
Product Description
-
Seller Information
-
Inquiry History
-
DescriptionECHEMI Editorial ReferenceButyric acid is a histone deacetylase (HDAC) inhibitor, with anti-tumor effects in several cancers.
Sodium butyrate is a compound with formula Na(C3H7COO). It is the sodium salt of butyric acid. It has various effects on cultured mammalian cells including inhibition of proliferation, induction of differentiation and induction or repression of gene expression. As such, it can be used in lab to bring about any of these effects. Specifically, butyrate treatment of cells results in histone hyperacetylation, and butyrate itself inhibits class I histone deacetylase (HDAC) activity, specifically HDAC1, HDAC2, HDAC3, and HDAC8. Butyrate has been an essential vehicle for determining the role of histone acetylation in chromatin structure and function. Inhibition of HDAC activity is estimated to affect the expression of only 2% of mammalian genes.
Liquid
Sodium butyrate is an organic sodium salt resulting from the replacement of the proton from the carboxy group of butyric acid by a sodium ion. It has a role as an EC 3.5.1.98 (histone deacetylase) inhibitor and a geroprotector. It contains a butyrate.|Sodium Butyrate is the sodium salt of butyrate with potential antineoplastic activity. Butyrate, a short chain fatty acid, competitively binds to the zinc sites of class I and II histone deacetylases (HDACs). This binding affects hyperacetylation of histones, resulting in a modified DNA conformation, which subsequently leads to the uncoiling or relaxing of chromatin. Enhanced accessibility of chromatin to transcription-regulatory complexes leads to increased transcriptional activation of various epigenetically suppressed genes. Butyrate, a HDAC inhibitor, induces cell cycle arrest in G1 or G2/M and also increases the expression of other genes and proteins involved in cellular differentiation and apoptotic signaling.|A four carbon acid, CH3CH2CH2COOH, with an unpleasant odor that occurs in butter and animal fat as the glycerol ester.Basic Info-
Product Name:
Sodium butyrate
Other Name:Butanoic acid,sodium salt (1:1);Butyric acid,sodium salt;Butanoic acid,sodium salt;Sodium butyrate;Sodium butanoate;Butyrate sodium;Sodium n-butyrate;Sodium propanecarboxylate;Gustor XXI B 70;Adimix
CAS No.:156-54-7
Molecular Formula:C4H8O2.Na
InChIKeys:InChIKey=SWEYNHYBJHPVJL-UHFFFAOYSA-N
Molecular Weight:110.09
Exact Mass:110.034370
BRN:3629439
EC Number:205-857-6
UNII:8RAS91C36W
DSSTox ID:DTXSID3037672
NCI Thesaurus Code:C2337
HScode:2915600000
Categories:
Characteristics-
PSA:
40.1
XLogP3:-3.2 (LogP)
Appearance:White Amorphous Powder
Density:0.987g/cm3
Melting Point:251 °C
Boiling Point:164.3°C at 760 mmHg
Flash Point:69.7ºC
Water Solubility:H2O: soluble
Storage Conditions:-20°C
Vapor Pressure:1.35mmHg at 25°C
Flammability characteristics:Combustible, the fire emits spicy sodium oxide to stimulate the smoke
Hazard IdentificationClassification of the substance or mixture
Skin irritation, Category 2
Eye irritation, Category 2
Specific target organ toxicity â single exposure, Category 3
Germ cell mutagenicity, Category 2
GHS label elements, including precautionary statements
Pictogram(s)
Signal word Warning
Hazard statement(s) H315 Causes skin irritation
H319 Causes serious eye irritation
H335 May cause respiratory irritation
H341 Suspected of causing genetic defects
Precautionary statement(s) Prevention P264 Wash ... thoroughly after handling.
P280 Wear protective gloves/protective clothing/eye protection/face protection/hearing protection/...
P261 Avoid breathing dust/fume/gas/mist/vapours/spray.
P271 Use only outdoors or in a well-ventilated area.
P203 Obtain, read and follow all safety instructions before use.
Response P302+P352 IF ON SKIN: Wash with plenty of water/...
P321 Specific treatment (see ... on this label).
P332+P317 If skin irritation occurs: Get medical help.
P362+P364 Take off contaminated clothing and wash it before reuse.
P305+P351+P338 IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing.
P304+P340 IF INHALED: Remove person to fresh air and keep comfortable for breathing.
P319 Get medical help if you feel unwell.
P318 IF exposed or concerned, get medical advice.
Storage P403+P233 Store in a well-ventilated place. Keep container tightly closed.
P405 Store locked up.
Disposal P501 Dispose of contents/container to an appropriate treatment and disposal facility in accordance with applicable laws and regulations, and product characteristics at time of disposal.
Other hazards which do not result in classification
no data available
Handling and StoragePrecautions for safe handling
Handling in a well ventilated place. Wear suitable protective clothing. Avoid contact with skin and eyes. Avoid formation of dust and aerosols. Use non-sparking tools. Prevent fire caused by electrostatic discharge steam.
Conditions for safe storage, including any incompatibilities
Store the container tightly closed in a dry, cool and well-ventilated place. Store apart from foodstuff containers or incompatible materials.
-
-
Seller Information
-
Business Type:
Manufactory
-
Main Products:
Acesulfame k,Aspartame,BCAA(Keratin hydrolyzed),Beta-alanine,Citric Acid,Conjugated Linoleic Acid Powder
-
Location:
FARMASINO PHARMACEUTICALS (JIANGSU) CO., LTD.
-
Payment Terms:
TT against copy of documents,D/P,L/C,D/A,O/A
-
Average lead Time:
10
-
Total Annual Revenue:
Above $100 million
-
Year of Establishment:
2008
FarmaSino Pharmaceuticals (Jiangsu) Co., Ltd (As “FarmaSino”) is one of the key subsidiaries of HIGH HOPE International Group , which is one of the largest companies in the "China Top 500”.It is mainly engaged in the R&D, Manufacturing and Distribution of Finished Drugs, Bulk Pharmaceutic
als, and Intermediates&Chemicals. Its commodities are being exported to more than 60 countries and regions in the world, trusted by customers from the globe.FarmaSino is an excellent company involved in many fields, and has improved its management by ISO9001 and endeavored to approach international advanced level all the time . Since it was founded, FarmaSino has constantly devoted to establishing business innovation, industrialization and branding. Based on its business, FarmaSino has built its own manufacture plants for Finished Drugs, Bulk Pharmaceuticals, and Intermediates & Chemicals . Also FarmaSino has established a R&D Centre which possesses advanced equipments and experienced experts.
FarmaSino has constantly emphasized that the core of its business is to establish the strategic alliance partnerships with both up-and-down-stream customers all over the world. Therefore FarmaSino has achieved high reputation in the field of pharmaceuticals, chemicals , agrochemicals and veterinary by offering top quality and personalized services to our customers.
"Clients’ satisfaction is our responsibility”, FarmaSino should be your best partner in Pharmaceutical and Chemicals business.
-
-
Inquiry History8 Inquiries
Country Product Purchase Quantity Date Posted
India
Sodium butyrate
100 MT Apr 2, 2025
South Korea
Sodium butyrate
2 G May 10, 2024
Poland
Sodium Butyrate
1 20' Fcl Aug 21, 2026
India
Feed Grade Coated Sodium Butyrate & Plainf Sodium Butyrate 99%
6000 KG Jan 20, 2026
Italy
Sodium Butyrate
50 KG Jan 23, 2024
India
Sodium butyrate
25.00 KG Jan 9, 2024
Jordan
Sodium Butyrate
1 MT Dec 23, 2024
United States
Sodium Butyrate
10 KG Jul 7, 2024 Post an enquiry for this product